Home » Stocks » BSGM

BioSig Technologies, Inc. (BSGM)

Stock Price: $3.07 USD 0.03 (0.99%)
Updated May 12, 2021 4:00 PM EDT - Market closed
Market Cap 99.95M
Revenue (ttm) n/a
Net Income (ttm) -52.23M
Shares Out 32.14M
EPS (ttm) -1.87
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 12
Last Price $3.07
Previous Close $3.04
Change ($) 0.03
Change (%) 0.99%
Day's Open 3.01
Day's Range 2.98 - 3.20
Day's Volume 117,482
52-Week Range 2.79 - 12.19

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform called ...

6 hours ago - Proactive Investors

The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases t...

1 week ago - Benzinga

BioSig Technologies Inc (NASDAQ:BSGM), which is commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardia...

1 week ago - Proactive Investors

BioSig Technologies, Inc. (NASDAQ:BSGM) has announced that physicians at Mayo Clinic's campus in Phoenix, Arizona have started using the company's PURE EP System in patient cases treating cardiac arrhyt...

2 weeks ago - Proactive Investors

Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal proces...

2 weeks ago - GlobeNewsWire

MedTech company BioSig Technologies, Inc.'s (NASDAQ: BSGM) first commercial product — the PURE EP system — is gaining traction with physicians and patients. What Happened: BioSig's PURE EP system, which...

2 weeks ago - Benzinga

BioSig Technologies Inc (NASDAQ:BSGM), which is commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, ...

3 weeks ago - Proactive Investors

Two seasoned MedTech sales executives join the Company to lead regional rollouts of the PURE EP System (TM), an electrophysiology system for arrhythmia procedures Two seasoned MedTech sales executives j...

3 weeks ago - GlobeNewsWire

BioSig Technologies, Inc. (NASDAQ:BSGM) has announced the release of the PURE EP Software Version 4. The latest release builds on the main system capabilities of the PURE EP while improving the overall ...

4 weeks ago - Proactive Investors

Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) -- The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular heartb...

4 weeks ago - GlobeNewsWire

BioSig Technologies Inc (NASDAQ:BSGM) said it has completed enrollment in the PURE EP 2.0 clinical trial. The multi-center, prospective clinical trial was conducted at the Texas Cardiac Arrhythmia Insti...

4 weeks ago - Proactive Investors

Westport, CT, April 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfo...

4 weeks ago - GlobeNewsWire

Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfo...

1 month ago - GlobeNewsWire

BioSig Technologies Inc (NASDAQ:BSGM) has seen its PURE EP System featured in the new edition of leading electrophysiology trade publication, EP Lab Digest. This is the second time that the computerized...

1 month ago - Proactive Investors

Westport, CT, April 08, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platfo...

1 month ago - GlobeNewsWire

Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform called ...

1 month ago - Proactive Investors

BioSig Technologies, Inc. (NASDAQ:BSGM) has announced that a top-rated leading hospital system has purchased the company's PURE EP systems for multiple campuses in its national network. “We are pleased ...

1 month ago - Proactive Investors

Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfo...

1 month ago - GlobeNewsWire

Westport, CT, April 05, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platfo...

1 month ago - GlobeNewsWire

BioSig Technologies Inc (NASDAQ:BSGM) said that US Patent Office has allowed a utility patent covering its PURE EP noise-filtering technology. The medical technology firm, which specializes in commercia...

1 month ago - Proactive Investors

Westport, CT, March 30, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfo...

1 month ago - GlobeNewsWire

BioSig Technologies Inc (NASDAQ:BSGM) founder, Chairman, and CEO Kenneth L. Londoner told investors on Monday that the commercial adoption of the company's first product called the PURE EP, which measur...

1 month ago - Proactive Investors

Westport, CT, March 29, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal proces...

1 month ago - GlobeNewsWire

Westport, CT, March 10, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platfo...

2 months ago - GlobeNewsWire

Westport, CT, March 09, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platfo...

2 months ago - GlobeNewsWire

BioSig Technologies, Inc. (NASDAQ:BSGM), has said the US Patent Office has allowed a utility patent that its majority-owned subsidiary NeuroClear Technologies, Inc. had exclusively licensed from the May...

2 months ago - Proactive Investors

Westport, CT, March 04, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfo...

2 months ago - GlobeNewsWire

BioSig Technologies, Inc. (NASDAQ:BSGM) announced Tuesday that it has appointed Brenda Castrodad to lead its Human Resources department. The medical technology company seasoned executive noted that Cast...

2 months ago - Proactive Investors

Seasoned medtech executive to scale up the Company's organizational development upon the increase in demand for the evaluative installations of the PURE EP System™ Seasoned medtech executive to scale up...

2 months ago - GlobeNewsWire

BioSig Technologies, Inc. (NASDAQ:BSGM) said it has entered into three new evaluation agreements for the PURE EP System, its novel electrophysiology (EP) signal acquisition and analysis technology. The ...

3 months ago - Proactive Investors

New 90-day evaluation cycles enable hospitals to more rapidly assess the platform technology while also accelerating BioSig's commercial activities New 90-day evaluation cycles enable hospitals to more ...

3 months ago - GlobeNewsWire

Westport, CT, Jan. 27, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platfor...

3 months ago - GlobeNewsWire

PURE EP(tm) System to be highlighted in a Spotlight session by G. Joseph Gallinghouse, M.D., Texas Cardiac Arrhythmia Institute PURE EP(tm) System to be highlighted in a Spotlight session by G. Joseph G...

3 months ago - GlobeNewsWire

Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfor...

3 months ago - GlobeNewsWire

Industry-leading smart glasses technology expected to enhance the utility of BioSig's PURE EP™ System signal processing platform. Remote servicing intended to enable continued installations, upgrades, a...

3 months ago - GlobeNewsWire

PURE EP(tm) system evaluation conducted under the leadership of Cardiologists Vinod Chauhan, M.D. and Deepak Gaba, M.D. Memorial Hospital is nationally recognized for its emphasis on innovation. PURE EP...

4 months ago - GlobeNewsWire

Westport, CT, Jan. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal processing p...

4 months ago - GlobeNewsWire

NeuroClear is set to commence experiments aimed at developing therapies for autonomic nervous system disease NeuroClear is set to commence experiments aimed at developing therapies for autonomic nervous...

4 months ago - GlobeNewsWire

BioSig Technologies, Inc. was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. According to recent information published on WHO's 2019 Global Healt...

4 months ago - Benzinga

BioSig Technologies Inc (NASDAQ: BSGM), a medical device company, announced Friday a commercial milestone with respect to its FDA-approved PURE EP Systems. What Happened: Westport, Connecticut-based Bio...

5 months ago - Benzinga

Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence

5 months ago - GlobeNewsWire

Westport, CT, Dec. 10, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal processing p...

5 months ago - GlobeNewsWire

Company's flagship product to be featured in live patient cases broadcast from the Texas Cardiac Arrhythmia Institute on December 3-4, 2020 Company's flagship product to be featured in live patient case...

5 months ago - GlobeNewsWire

BioSig Technologies, Inc. (BSGM) CEO Ken Londoner on Business Development Update Conference Call (Transcript)

5 months ago - Seeking Alpha

Westport, CT, Nov. 12, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing a proprietary biomedical signal process...

6 months ago - GlobeNewsWire

First Patient Cases with PURE EP System Conducted at Deborah Heart and Lung Center First Patient Cases with PURE EP System Conducted at Deborah Heart and Lung Center

6 months ago - GlobeNewsWire

Westport, CT, Oct. 28, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal process...

6 months ago - GlobeNewsWire

BioSig Technologies Inc. (NASDAQ: BSGM) was absolutely crushed on Monday after the company announced that it would halt its midstage coronavirus study.

6 months ago - 24/7 Wall Street

Shares of Biosig Technologies Inc. plunged 39.0% in active morning trading Monday, enough to pace all Nasdaq decliners, after the medical technology company halted a trial of its COVID-19 treatment give...

6 months ago - Market Watch

Westport, CT, Oct. 26, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its majority owned subsidiary, ViralClear Pharmaceuticals, Inc. (ViralClear), ann...

6 months ago - GlobeNewsWire

About BSGM

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial... [Read more...]

Industry
Medical Devices
Founded
2009
Stock Exchange
NASDAQ
Ticker Symbol
BSGM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for BSGM stock is "Buy" and the 12-month stock price forecast is 13.00.

Price Target
$13.00
Analyst Consensus: Buy